 |
|
|
|
| Guidelines |
 CDC. 2004-05 interim guidance for the use of masks to control influenza transmission. Nov 19, 2004 [Full text]
CDC. CDC guidelines for large-scale influenza vaccination clinic planning. May 23, 2007 [Full text]
CDC. CDC guidelines for large-scale influenza vaccination clinic planning: guidelines for the tiered use of inactivated influenza vaccine. May 23, 2007 [Full text]
CDC. Destruction of influenza A (H2N2) proficiency testing samples; interim guidance for biosafety level 3-enhanced biocontainment for work with human influenza A (H2N2) viruses. May 3, 2005 [Full text]
CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR 2007 Jun 29;56(Early Release):1-54 [Full text]
CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2006 Jun 28;55(Early release):1-41 [Full text]
FDA. Guidance for industry: clinical data needed to support the licensure of seasonal inactivated influenza vaccines. May 31, 2007 [Full text]
IDSA (Infectious Diseases Society of America). Pandemic and seasonal influenza principles for US action. Released Jan 25, 2007 [Full text]
NICE (UK National Institute for Health and Clinical Excellence). Influenza (prophylaxis): amantadine, oseltamivir and zanamivir. Sep 24, 2008 [Full text of several guidance documents]
|
